Live Breaking News & Updates on Biopharmaceutical Product Development

Stay updated with breaking news from Biopharmaceutical product development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GreenLight Biosciences Welcomes Amin Khan As Chief Scientific Officer, Human Health


GreenLight Biosciences Welcomes Amin Khan As Chief Scientific Officer, Human Health
BOSTON, April 28, 2021 /PRNewswire/ GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, today announced the appointment of Amin Khan as the company s Chief Scientific Officer, Human Health.
Khan joins GreenLight from GSK s Vaccines business where he was a member of their R&D leadership team. He headed their Technical R&D organization, and recently led Vaccines R&D Acceleration, where he was responsible for end-to-end accelerated development of the vaccine portfolio.
GreenLight aims to address humanity s greatest challenges, from producing vaccines to protecting bees, said Andrey Zarur, CEO of GreenLight Biosciences. Amin brings deep experience developing and launching vaccines, which will be critical to our mission to democratize healthcare. ....

United States , Amin Khan , Andrey Zarur , Continental Grain Company , Biopharmaceutical Product Development , Human Health , Prnewswire Greenlight Biosciences Inc , Light Biosciences , Chief Scientific Officer , Vaccines Rd Acceleration , Design An Indispensable Approach , Accelerate Biopharmaceutical Product Development , Baird Capital , Cormorant Asset Management , Fall Line , Lupa Systems Capital , ஒன்றுபட்டது மாநிலங்களில் , அமின் காந் , கண்டம் தானிய நிறுவனம் , மனிதன் ஆரோக்கியம் , ஒளி உயிர் அறிவியல் , தலைமை அறிவியல் அதிகாரி , பெயர்ட் மூலதனம் , கர்மரண்ட் சொத்து மேலாண்மை , வீழ்ச்சி வரி , லூபா அமைப்புகள் மூலதனம் ,